Free Trial

UBS Group (UBS) Financials

UBS Group logo
$46.36 +0.08 (+0.16%)
Closing price 03:59 PM Eastern
Extended Trading
$46.40 +0.05 (+0.10%)
As of 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for UBS Group

Annual Income Statements for UBS Group

This table shows UBS Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
6,571 4,622 1,123 4,516 4,304 6,557 7,457 7,630 10,617 5,085 3,202
Consolidated Net Income / (Loss)
6,388 3,432 1,046 4,522 4,310 6,572 7,486 7,661 27,382 5,146 7,797
Net Income / (Loss) Continuing Operations
6,389 4,622 1,046 4,523 4,310 6,572 7,486 7,662 10,601 1,882 3,172
Total Pre-Tax Income
5,490 5,399 5,351 5,991 5,577 8,155 9,484 9,604 11,474 6,821 4,228
Total Revenue
30,613 35,630 29,622 30,213 28,889 33,084 35,393 34,563 24,801 48,611 39,600
Net Interest Income / (Expense)
6,617 0.00 6,070 5,048 4,501 5,862 6,705 6,621 -20,919 7,108 -18,797
Total Interest Income
13,180 0.00 12,703 11,438 11,695 8,810 8,533 11,782 7,297 35,994 7,747
Investment Securities Interest Income
13,180 - 10,422 10,100 10,684 8,810 8,533 11,782 7,297 35,994 7,747
Total Interest Expense
6,564 0.00 6,632 6,391 7,194 4,247 3,259 6,564 28,216 35,947 26,544
Other Interest Expense
6,564 - 6,632 6,391 7,194 4,247 3,259 6,564 28,216 35,947 26,544
Total Non-Interest Income
23,995 35,630 23,552 25,165 24,389 26,528 28,837 27,913 45,720 40,952 58,397
Other Service Charges
1,107 35,630 524 428 212 1,076 452 1,459 45,720 675 58,397
Total Non-Interest Expense
25,123 31,315 24,272 24,222 23,312 24,235 26,058 24,930 28,680 41,239 55,726
Salaries and Employee Benefits
15,985 1,781 16,199 16,132 16,084 17,224 18,387 17,680 2,195 27,318 2,669
Other Operating Expenses
8,109 28,444 6,949 6,797 5,288 4,885 5,553 5,189 22,735 10,124 49,528
Depreciation Expense
920 997 1,053 1,228 1,940 2,126 2,118 2,061 3,750 - 3,529
Nonoperating Income / (Expense), net
- 1,084 - - - 1,299 1,431 1,403 15,353 - 20,354
Income Tax Expense
-898 777 4,305 1,468 1,267 1,583 1,998 1,942 873 1,675 1,056
Net Income / (Loss) Attributable to Noncontrolling Interest
-183 - -77 -7.00 -6.00 -15 -29 -32 -16 -60 -30
Weighted Average Basic Shares Outstanding
- - 7.71B 1.21 7.72B 7.72B 7.56B 7.38B 8.68 3.46B 2.46
Diluted Earnings per Share
$1.64 - $0.25 $1.18 $1.14 $1.77 $2.06 $2.25 $8.30 $1.52 $2.36
Weighted Average Diluted Shares Outstanding
- - 7.71B 7.71B 7.72B 7.72B 7.56B 7.38B 3.46B 3.46B 3.34B
Weighted Average Basic & Diluted Shares Outstanding
- - 7.71B 7.71B 7.72B 7.72B 7.56B 7.38B 3.46B 3.46B 3.34B

Quarterly Income Statements for UBS Group

No quarterly income statements for UBS Group are available.


Annual Cash Flow Statements for UBS Group

This table details how cash moves in and out of UBS Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-11,931 17,733 -19,925 22,971 -7,467 42,605 39,651 -6,895 -49,456 -175,814 -141,640
Net Cash From Operating Activities
3,110 -18,292 -52,099 -28,913 19,705 36,958 31,425 14,647 109,299 5,010 8,718
Net Cash From Continuing Operating Activities
3,109 -18,290 -52,100 28,849 19,705 18,810 31,377 2,653 109,299 5,010 8,718
Net Income / (Loss) Continuing Operations
6,388 3,432 1,046 4,522 4,310 6,572 7,486 7,661 27,382 5,146 7,797
Consolidated Net Income / (Loss)
6,388 3,432 1,046 4,522 4,310 6,572 7,486 7,661 27,382 5,146 7,797
Depreciation Expense
920 997 1,053 1,228 1,940 2,126 2,118 2,061 3,750 3,798 3,529
Non-Cash Adjustments to Reconcile Net Income
-364 8,334 4,532 -6,038 8,077 -4,566 3,853 -19,272 -208 -4,466 -1,477
Changes in Operating Assets and Liabilities, net
-3,942 -31,146 -58,802 29,137 5,378 14,678 17,920 12,203 78,375 532 -1,131
Net Cash From Investing Activities
-8,443 36,637 5,186 -6,132 -1,558 -6,785 -2,119 -12,447 676 964 1,051
Net Cash From Continuing Investing Activities
-8,442 36,636 5,368 -6,132 -1,558 -6,786 -954 245 676 964 1,051
Purchase of Property, Leasehold Improvements and Equipment
-1,841 -1,800 -1,627 -1,688 -1,584 -1,854 -1,841 -1,643 -1,620 -1,900 -2,153
Sale and/or Maturity of Investments
93,608 54,433 15,341 1,361 3,913 4,530 - - 2,296 2,864 3,204
Net Cash From Financing Activities
-6,597 -612 26,988 190 -25,614 12,432 10,345 -9,094 -159,431 -181,788 -151,409
Net Cash From Continuing Financing Activities
-6,598 -612 26,987 191 -25,614 12,433 10,346 -9,095 -159,431 -181,788 -151,409
Repayment of Debt
- -33,902 -45,187 -44,344 -68,883 -87,098 -79,909 -67,670 -162,818 -179,677 -152,922
Other Financing Activities, Net
-1,001 -2,646 -787 -1,462 -526 -575 -282 -6,623 3,387 -2,111 1,513
Cash Interest Received
11,147 8,002 12,708 14,645 15,315 11,915 11,163 15,718 44,581 53,498 42,589
Cash Income Taxes Paid
- - - - - - - - 1,852 1,938 2,049

Quarterly Cash Flow Statements for UBS Group

No quarterly cash flow statements for UBS Group are available.


Annual Balance Sheets for UBS Group

This table presents UBS Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/1/2017 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
918,906 939,279 958,489 972,194 1,125,765 1,117,182 1,104,364 1,716,924 1,565,028 1,617,427
Cash and Due from Banks
105,883 90,045 108,370 107,068 158,231 192,817 169,445 314,060 223,329 209,858
Trading Account Securities
154,626 189,864 187,060 211,458 205,761 190,901 167,662 273,651 254,537 282,274
Loans and Leases, Net of Allowance
312,936 340,840 337,220 339,233 394,972 413,241 402,012 660,815 598,870 673,495
Loans and Leases
312,936 340,840 337,220 339,233 394,972 413,241 402,012 660,815 598,870 673,495
Premises and Equipment, Net
8,186 9,057 9,348 12,804 13,109 12,888 12,288 17,849 15,498 16,057
Goodwill
6,442 6,563 6,647 6,469 6,480 6,378 6,267 7,515 6,887 6,948
Other Assets
330,832 302,911 309,845 295,162 347,212 270,442 311,657 443,034 465,905 428,796
Total Liabilities & Shareholders' Equity
918,906 939,279 958,489 972,194 1,125,765 1,117,182 1,104,364 1,716,924 1,565,028 1,617,427
Total Liabilities
865,320 886,725 905,386 917,519 1,066,000 1,056,180 1,047,146 1,630,769 1,479,454 1,526,944
Non-Interest Bearing Deposits
416,267 419,577 419,838 448,284 524,605 542,007 525,051 792,029 745,777 788,367
Short-Term Debt
9,266 17,485 48,716 45,011 45,063 49,578 49,287 56,916 63,856 78,427
Long-Term Debt
150,894 193,942 189,302 177,306 200,475 212,954 188,259 366,106 322,128 328,500
Other Long-Term Liabilities
288,892 255,721 247,529 246,919 295,857 251,640 284,548 415,720 347,695 331,650
Total Equity & Noncontrolling Interests
53,586 52,554 53,092 54,675 59,765 61,002 57,218 86,156 85,574 90,484
Total Preferred & Common Equity
52,916 52,495 52,928 54,501 59,445 60,662 56,876 85,624 85,079 90,213
Preferred Stock
25,958 23,598 20,843 18,064 16,753 15,928 13,546 13,216 12,012 9,217
Total Common Equity
26,958 28,898 32,085 36,437 42,693 44,734 43,331 72,409 73,067 80,996
Common Stock
338 338 338 338 338 322 304 346 346 334
Retained Earnings
25,029 25,932 30,448 34,122 38,776 43,851 50,004 74,397 78,035 82,740
Treasury Stock
-2,362 -2,210 -2,631 -3,326 -4,068 -4,675 -6,874 -4,796 -6,402 -7,891
Accumulated Other Comprehensive Income / (Loss)
3,953 4,838 3,930 5,303 7,647 5,236 -103 2,462 1,088 5,813
Noncontrolling Interest
670 59 176 174 319 340 342 531 494 271

Quarterly Balance Sheets for UBS Group

This table presents UBS Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q4 2023 Q4 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets
1,104,364 1,716,924 1,565,028
Cash and Due from Banks
169,445 314,060 223,329
Trading Account Securities
167,662 273,651 254,537
Loans and Leases, Net of Allowance
402,012 660,815 598,870
Loans and Leases
402,012 660,815 598,870
Premises and Equipment, Net
12,288 17,849 15,498
Goodwill
6,267 7,515 6,887
Other Assets
311,657 443,034 465,905
Total Liabilities & Shareholders' Equity
1,104,364 1,716,924 1,565,028
Total Liabilities
1,047,146 1,630,769 1,479,454
Non-Interest Bearing Deposits
525,051 792,029 745,777
Short-Term Debt
49,287 56,916 63,856
Long-Term Debt
188,259 366,106 322,128
Other Long-Term Liabilities
284,548 415,720 347,695
Total Equity & Noncontrolling Interests
57,218 86,156 85,574
Total Preferred & Common Equity
56,876 85,624 85,079
Preferred Stock
13,546 13,216 12,012
Total Common Equity
43,331 72,409 73,067
Common Stock
304 346 346
Retained Earnings
50,004 74,397 78,035
Treasury Stock
-6,874 -4,796 -6,402
Accumulated Other Comprehensive Income / (Loss)
-103 2,462 1,088
Noncontrolling Interest
342 531 494

Annual Metrics And Ratios for UBS Group

This table displays calculated financial ratios and metrics derived from UBS Group's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 3,341,581,714.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 3,341,581,714.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 2.33
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 16.39% -16.86% 2.00% -4.38% 14.52% 6.98% -2.35% 39.74% 0.64% -18.54%
EBITDA Growth
0.00% -17.07% 19.78% 12.51% 3.20% 46.00% 4.36% 2.10% 171.40% -64.81% -212.78%
EBIT Growth
0.00% -21.41% 23.99% 11.98% -6.91% 58.67% 5.49% 3.19% 190.54% -73.66% -318.75%
NOPAT Growth
0.00% -42.18% -71.68% 332.41% -4.71% 28.19% 15.05% 2.93% 327.77% -100.65% -335.10%
Net Income Growth
0.00% -46.27% -69.52% 332.31% -4.69% 52.48% 13.91% 2.34% 614.84% -90.60% 51.52%
EPS Growth
0.00% 0.00% 0.00% 372.00% -3.39% 55.26% 16.38% 9.22% 0.00% 0.00% 55.26%
Operating Cash Flow Growth
0.00% -688.20% -184.82% 44.50% 168.15% 87.56% -14.97% -53.39% 646.22% -99.66% 74.01%
Free Cash Flow Firm Growth
0.00% 0.00% 76.58% 54.02% 181.53% -223.57% 47.89% 397.38% -627.93% 120.08% -188.74%
Invested Capital Growth
0.00% 0.00% 23.50% 10.28% -4.85% 10.22% 5.97% -8.89% 72.74% -7.39% 5.48%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
21.29% 15.17% 21.86% 24.11% 26.02% 33.17% 32.36% 33.83% 65.71% 22.98% -31.81%
EBIT Margin
17.94% 12.11% 18.06% 19.83% 19.30% 26.75% 26.38% 27.87% 57.95% 15.17% -40.72%
Profit (Net Income) Margin
20.87% 9.63% 3.53% 14.97% 14.92% 19.86% 21.15% 22.17% 113.38% 10.59% 19.69%
Tax Burden Percent
116.34% 63.57% 19.55% 75.48% 77.28% 80.59% 78.93% 79.77% 195.67% 75.44% 184.41%
Interest Burden Percent
100.00% 125.12% 100.02% 100.00% 100.00% 92.16% 101.60% 99.70% 100.00% 92.53% -26.22%
Effective Tax Rate
-16.36% 14.39% 80.45% 24.50% 22.72% 19.41% 21.07% 20.22% 0.00% 24.56% 24.98%
Return on Invested Capital (ROIC)
0.00% 3.46% 0.44% 1.63% 1.52% 1.90% 2.02% 2.12% 6.96% -0.04% -2.50%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 3.13% 0.44% 1.63% 1.52% 2.35% 2.47% 2.56% 15.07% 1.28% 2.52%
Return on Net Nonoperating Assets (RNNOA)
0.00% 9.35% 1.53% 6.93% 6.48% 9.59% 10.38% 10.84% 69.43% 6.03% 11.35%
Return on Equity (ROE)
0.00% 12.81% 1.97% 8.56% 8.00% 11.49% 12.40% 12.96% 76.39% 5.99% 8.86%
Cash Return on Invested Capital (CROIC)
0.00% -196.54% -20.59% -8.15% 6.49% -7.83% -3.78% 11.42% -46.38% 7.63% -7.83%
Operating Return on Assets (OROA)
0.00% 0.47% 0.58% 0.63% 0.58% 0.84% 0.83% 0.87% 1.98% 0.45% -1.01%
Return on Assets (ROA)
0.00% 0.37% 0.11% 0.48% 0.45% 0.63% 0.67% 0.69% 3.88% 0.31% 0.49%
Return on Common Equity (ROCE)
0.00% 6.44% 1.04% 4.94% 5.09% 7.94% 8.97% 9.65% 61.67% 5.08% 7.75%
Return on Equity Simple (ROE_SIMPLE)
0.00% 6.49% 1.99% 8.54% 7.91% 11.06% 12.34% 13.47% 63.96% 6.05% 8.64%
Net Operating Profit after Tax (NOPAT)
6,389 3,694 1,046 4,523 4,310 5,525 6,356 6,543 27,988 -181 -12,098
NOPAT Margin
20.87% 10.37% 3.53% 14.97% 14.92% 16.70% 17.96% 18.93% 57.95% -0.37% -30.55%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.33% 0.00% 0.00% 0.00% -0.45% -0.44% -0.45% -8.11% -1.32% -5.02%
SG&A Expenses to Revenue
52.22% 5.00% 54.69% 53.39% 55.68% 52.06% 51.95% 51.15% 0.00% 56.20% 6.74%
Operating Expenses to Revenue
82.07% 87.89% 81.94% 80.17% 80.70% 73.25% 73.62% 72.13% 42.05% 84.83% 140.72%
Earnings before Interest and Taxes (EBIT)
5,490 4,315 5,350 5,991 5,577 8,849 9,335 9,633 27,988 7,372 -16,126
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6,518 5,405 6,474 7,284 7,517 10,975 11,453 11,694 31,738 11,170 -12,597
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 2.46 2.33 2.37 2.89 3.09 3.07 1.44 1.98
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 3.11 2.83 2.79 3.37 3.62 3.43 1.59 2.17
Price to Revenue (P/Rev)
0.00 0.00 0.00 2.62 2.93 3.05 3.65 3.88 4.60 2.16 4.05
Price to Earnings (P/E)
0.00 0.00 0.00 17.51 19.69 15.40 17.32 17.57 7.94 20.64 50.07
Dividend Yield
7.54% 9.41% 4.10% 6.32% 6.27% 5.09% 5.09% 1.41% 1.83% 2.31% 3.46%
Earnings Yield
0.00% 0.00% 0.00% 5.71% 5.08% 6.49% 5.77% 5.69% 12.59% 4.84% 2.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.79 0.79 0.67 0.57 0.61 0.68 0.59 0.74
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 7.60 7.55 6.21 5.22 5.24 7.14 5.76 9.26
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 31.54 29.03 18.71 16.12 15.48 10.87 25.08 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 38.35 39.13 23.21 19.78 18.79 12.33 38.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 50.79 50.64 37.17 29.05 27.66 12.33 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 11.08 5.56 5.88 12.36 3.16 747.02 42.08
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 11.84 0.00 0.00 5.13 0.00 7.48 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 2.99 4.02 4.48 4.07 4.11 4.30 4.15 4.91 4.51 4.50
Long-Term Debt to Equity
0.00 2.82 3.69 3.57 3.24 3.35 3.49 3.29 4.25 3.76 3.63
Financial Leverage
0.00 2.99 3.50 4.25 4.27 4.09 4.21 4.23 4.61 4.71 4.50
Leverage Ratio
0.00 17.15 17.51 17.96 17.92 18.33 18.57 18.79 19.68 19.11 18.08
Compound Leverage Factor
0.00 21.46 17.51 17.96 17.92 16.89 18.87 18.74 19.68 17.68 -4.74
Debt to Total Capital
0.00% 74.93% 80.09% 81.76% 80.26% 80.42% 81.15% 80.59% 83.08% 81.85% 81.81%
Short-Term Debt to Total Capital
0.00% 4.34% 6.62% 16.73% 16.25% 14.76% 15.32% 16.72% 11.18% 13.54% 15.77%
Long-Term Debt to Total Capital
0.00% 70.60% 73.47% 65.03% 64.01% 65.66% 65.82% 63.87% 71.90% 68.31% 66.04%
Preferred Equity to Total Capital
0.00% 12.14% 8.94% 7.16% 6.52% 5.49% 4.92% 4.60% 2.60% 2.55% 1.85%
Noncontrolling Interests to Total Capital
0.00% 0.31% 0.02% 0.06% 0.06% 0.10% 0.11% 0.12% 0.10% 0.10% 0.05%
Common Equity to Total Capital
0.00% 12.61% 10.95% 11.02% 13.15% 13.98% 13.83% 14.70% 14.22% 15.49% 16.28%
Debt to EBITDA
0.00 29.63 32.66 32.68 29.58 22.37 22.92 20.31 13.33 34.56 -32.30
Net Debt to EBITDA
0.00 10.04 18.75 17.80 15.33 7.96 3.42 2.83 3.43 14.56 -15.64
Long-Term Debt to EBITDA
0.00 27.92 29.96 25.99 23.59 18.27 18.59 16.10 11.54 28.84 -26.08
Debt to NOPAT
0.00 43.36 202.13 52.62 51.58 44.44 41.30 36.31 15.11 -2,131.75 -33.64
Net Debt to NOPAT
0.00 14.69 116.04 28.66 26.74 15.80 6.17 5.05 3.89 -898.33 -16.29
Long-Term Debt to NOPAT
0.00 40.85 185.41 41.85 41.14 36.28 33.50 28.77 13.08 -1,779.08 -27.15
Noncontrolling Interest Sharing Ratio
0.00% 49.69% 47.38% 42.28% 36.42% 30.85% 27.61% 25.51% 19.27% 15.29% 12.49%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -210,052 -49,189 -22,617 18,439 -22,786 -11,875 35,313 -186,425 37,438 -37,950
Operating Cash Flow to CapEx
239.34% -1,130.53% -3,297.41% -1,836.91% 1,252.70% 2,483.74% 2,032.66% 988.33% 6,746.85% 19.74% 404.92%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -7.42 -3.54 2.56 -5.37 -3.64 5.38 0.00 1.04 -1.43
Operating Cash Flow to Interest Expense
0.47 0.00 -7.86 -4.52 2.74 8.70 9.64 2.23 0.00 0.01 0.33
Operating Cash Flow Less CapEx to Interest Expense
0.28 0.00 -8.09 -4.77 2.52 8.35 9.17 2.01 0.00 -0.04 0.25
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02
Fixed Asset Turnover
0.00 4.35 3.44 3.28 2.61 2.55 2.72 2.75 3.21 2.92 2.51
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 213,746 263,981 291,121 276,992 305,303 323,534 294,764 509,177 471,558 497,410
Invested Capital Turnover
0.00 0.33 0.12 0.11 0.10 0.11 0.11 0.11 0.12 0.10 0.08
Increase / (Decrease) in Invested Capital
0.00 213,746 50,235 27,140 -14,129 28,311 18,231 -28,770 214,413 -37,619 25,852
Enterprise Value (EV)
0.00 0.00 0.00 229,743 218,246 205,352 184,646 180,999 344,994 280,131 366,886
Market Capitalization
0.00 0.00 0.00 79,076 84,759 100,973 129,177 134,042 222,285 104,970 160,329
Book Value per Share
$0.00 $0.00 $3.75 $4.16 $4.72 $5.53 $5.80 $5.73 $9.81 $21.10 $23.40
Tangible Book Value per Share
$0.00 $0.00 $2.90 $3.30 $3.88 $4.69 $4.97 $4.90 $8.79 $19.12 $21.39
Total Capital
0.00 213,746 263,981 291,110 276,992 305,303 323,534 294,764 509,178 471,558 497,411
Total Debt
0.00 160,160 211,427 238,018 222,317 245,538 262,532 237,546 423,022 385,984 406,927
Total Long-Term Debt
0.00 150,894 193,942 189,302 177,306 200,475 212,954 188,259 366,106 322,128 328,500
Net Debt
0.00 54,277 121,382 129,648 115,249 87,307 39,201 33,069 108,962 162,655 197,069
Capital Expenditures (CapEx)
1,299 1,618 1,580 1,574 1,573 1,488 1,546 1,482 1,620 1,900 2,153
Net Nonoperating Expense (NNE)
1.00 262 0.00 1.00 0.00 -1,047 -1,130 -1,118 -26,776 -5,327 -19,895
Net Nonoperating Obligations (NNO)
0.00 160,160 211,427 238,029 222,317 245,538 262,532 237,546 423,021 385,984 406,926
Total Depreciation and Amortization (D&A)
1,027 1,090 1,124 1,293 1,940 2,126 2,118 2,061 3,750 3,798 3,529
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.28 $0.00 $1.17 $0.00 $2.14 $2.34 $0.00 $1.59 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 7.71B 7.71B 7.72B 2.00 7.56B 7.38B 3.46B 3.46B 2.00
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.27 $0.00 $1.14 $1.77 $2.06 $2.25 $0.00 $1.52 $2.36
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 7.71B 7.71B 7.72B 7.72B 7.56B 7.38B 3.46B 3.46B 3.34B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 7.71B 7.71B 7.72B 7.72B 7.56B 7.38B 3.46B 3.46B 3.34B
Normalized Net Operating Profit after Tax (NOPAT)
3,843 3,694 3,746 4,523 4,310 5,525 6,356 6,543 19,592 -181 -12,098
Normalized NOPAT Margin
12.55% 10.37% 12.65% 14.97% 14.92% 16.70% 17.96% 18.93% 40.56% -0.37% -30.55%
Pre Tax Income Margin
17.94% 15.15% 18.06% 19.83% 19.30% 24.65% 26.80% 27.79% 57.95% 14.03% 10.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.84 0.00 0.81 0.94 0.78 2.08 2.86 1.47 0.00 0.21 -0.61
NOPAT to Interest Expense
0.97 0.00 0.16 0.71 0.60 1.30 1.95 1.00 0.00 -0.01 -0.46
EBIT Less CapEx to Interest Expense
0.64 0.00 0.57 0.69 0.56 1.73 2.39 1.24 0.00 0.15 -0.69
NOPAT Less CapEx to Interest Expense
0.78 0.00 -0.08 0.46 0.38 0.95 1.48 0.77 0.00 -0.06 -0.54
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
43.22% 94.43% 215.97% 53.96% 59.03% 39.67% 17.38% 21.77% 0.00% 0.00% 0.00%
Augmented Payout Ratio
735.69% 94.43% 285.76% 53.96% 95.20% 60.77% 62.01% 21.77% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for UBS Group

No quarterly metrics and ratios for UBS Group are available.



Financials Breakdown Chart

Key Financial Trends

UBS Group’s balance sheet over the last four years shows a surge in scale and capital adequacy in 2023, followed by some moderation in 2024. The bank’s capital base strengthened notably, while liquidity metrics pulled back modestly in 2024. Here are the most important takeaways:

  • Total Common Equity grew from about $43.3B in 2022 to $72.4B in 2023 and $73.1B in 2024, signaling a substantially stronger core capital base.
  • Retained Earnings rose from about $50.0B in 2022 to $74.4B in 2023 and $78.0B in 2024, supporting a larger cumulative earnings base on the balance sheet.
  • Total Equity & Noncontrolling Interests remained robust around $85–86B, with $85.6B in 2024 (vs $57.2B in 2022 and $86.2B in 2023), indicating a solid equity cushion.
  • Trading Account Securities stayed large, at about $254.5B in 2024 after rising from $167.7B in 2022 and peaking at $273.7B in 2023, signaling strong liquidity/trading capacity.
  • Premises and Equipment Net increased to about $15.5B in 2024 from $12.3B in 2022, reflecting ongoing asset base expansion.
  • Total Assets surged to about $1.717T in 2023, then moderated to about $1.565T in 2024, indicating a year of rapid growth followed by consolidation.
  • Long-Term Debt rose to about $366.1B in 2023 and then moderated to about $322.1B in 2024, suggesting a shift in leverage mix over the period.
  • Non-Interest Bearing Deposits remained very large, at roughly $792.0B in 2023 and $745.8B in 2024, signaling stable core funding despite a modest 2024 decline.
  • Short-Term Debt increased from about $56.9B in 2023 to $63.9B in 2024, reflecting a modest uptick in near-term funding needs.
  • Total Liabilities grew from about $1.047T in 2022 to $1.631T in 2023, then declined to about $1.479T in 2024, signaling a shift in overall liability levels over the period.
  • Cash and Due from Banks declined from about $314.1B in 2023 to $223.3B in 2024, signaling tighter near-term liquidity versus the prior year.
  • Total Assets declined from about $1.717T in 2023 to $1.565T in 2024, indicating a reduction in the size of the balance sheet year over year.
05/14/26 05:30 PM ETAI Generated. May Contain Errors.

UBS Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, UBS Group's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

UBS Group's net income appears to be on an upward trend, with a most recent value of $7.80 billion in 2025, rising from $6.39 billion in 2015. The previous period was $5.15 billion in 2024. View UBS Group's forecast to see where analysts expect UBS Group to go next.

Over the last 10 years, UBS Group's total revenue changed from $30.61 billion in 2015 to $39.60 billion in 2025, a change of 29.4%.

UBS Group's total liabilities were at $1.53 trillion at the end of 2025, a 3.2% increase from 2024, and a 76.5% increase since 2016.

In the past 9 years, UBS Group's cash and equivalents has ranged from $90.05 billion in 2017 to $314.06 billion in 2023, and is currently $209.86 billion as of their latest financial filing in 2025.

Over the last 10 years, UBS Group's book value per share changed from 0.00 in 2015 to 23.40 in 2025, a change of 2,339.5%.



Financial statements for NYSE:UBS last updated on 3/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners